Meta-analysis of Clinical Outcomes Using Ceftazidime/Avibactam, Ceftolozane/Tazobactam, and Meropenem/Vaborbactam for the Treatment of Multidrug-Resistant Gram-Negative Infections.

Wilson, Geneva M; Fitzpatrick, Margaret; Walding, Kyle; Gonzalez, Beverly; Schweizer, Marin L; Suda, Katie J; Evans, Charlesnika T

Wilson, Geneva M; Fitzpatrick, Margaret; Walding, Kyle; Gonzalez, Beverly; Schweizer, Marin L; Suda, Katie J; Evans, Charlesnika T.

Afiliação

Wilson GM; Center of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr. Veterans Affairs Hospital, Hines, Illinois, USA.
Fitzpatrick M; Center of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr. Veterans Affairs Hospital, Hines, Illinois, USA.
Walding K; Loyola Medical Center, Maywood, Illinois, USA.
Gonzalez B; Loyola Medical Center, Maywood, Illinois, USA.
Schweizer ML; Center of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr. Veterans Affairs Hospital, Hines, Illinois, USA.
Suda KJ; College of Public Health, University of Iowa, Iowa City, Iowa, USA.
Evans CT; Center for Access and Delivery Research and Evaluation (CADRE), Iowa City VA Health Care System, Iowa City, Iowa, USA.

Open Forum Infect Dis ; 8(2): ofaa651, 2021 Feb.

Article em En | MEDLINE | ID: mdl-33598503

Palavras-chave

antimicrobial resistance; epidemiology; meta-analysis; multidrug-resistant infections

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google